FNYS
VTAE

First New York Securities’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

First New York Securities’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,437
Closed -$51K – 277
2016
Q3 		$51K Buy
+2,437
New +$28.1K 0.03% 125

First New York Securities's VTAE Position: Q4 2016 in Review

First New York Securities sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 2,437 shares — an estimated $51K sold.

First New York Securities first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $51K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • First New York Securities reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • First New York Securities sold 2,437 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $51K.
  • First New York Securities first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
  • First New York Securities's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $51K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on First New York Securities's 13F filing for Q4 2016, filed 7 Feb 2017.